February 01, 2023 article Open access Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma Blood Advances DOI: 10.1182/bloodadvances.2022009019 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 2 stored of 150 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands 2023 Cancers article Medicine CAR-T cell therapy research Open access 23 citations Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations 2023 Blood article Medicine CAR-T cell therapy research Open access cited by 1 patent 355 citations 2 results References 0